BPC 157: Experimental Peptide Creates Risk for Athletes The Food and Drug Administration will hold a meeting this summer to consider easing restrictions on more than a half dozen peptide injections, a group of unapproved therapies that have become popular The Hidden Risks of BPC157: What Patients Need to Know About Contamination and Safety Regenexx at New Regeneration Orthopedics The FDA has issued clear signals on BPC 157: it is not approved for human use in any form due to potential significant safety risks. This critical classification profoundly impacts research and Is BPC 157 Banned? Oral vs. Injectable Forms Explained FDA mulls compounding for peptides previously flagged over safety risks BioSpace